Arthritis is condition that causes pain and inflammation in joints. Around 100 different types of arthritis related conditions present globally and it is one of the leading cause of disability worldwide. The most common types of arthritis includes: Psoriatic Arthritis, Rheumatoid Arthritis, Osteoarthritis, are among others.
Growing burden of incidence of osteoarthritis, psoriatic arthritis and rheumatoid arthritis patients are major factors driving the growth of global arthritis drugs market. According to CDC estimation from 2010-2012, about 52.5 million US adults had some form of arthritis conditions among them persons with age 65 or older reported higher prevalence of arthritis conditions than the other ages due to “wear and tear” on the joints. However, due to lack of proper medication to cure arthritis and higher cost of the medications are hindering the growth of this market over the forecast period.
The global Arthritis Drug market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Arthritis Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Arthritis Drug market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Arthritis Drug in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Arthritis Drug manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
Novartis
Eli Lilly
Celltrion
F. Hoffmann-La Roche
Pfizer
Johnson & Johnson
GSK
...
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
Synthetic DMARDs
Biological DMARDs
NSAIDs
Corticosteroids
Analgesics
Segment by Application
Retail Pharmacies
Hospital Pharmacies
Drug Stores
E-Commerce
Growing burden of incidence of osteoarthritis, psoriatic arthritis and rheumatoid arthritis patients are major factors driving the growth of global arthritis drugs market. According to CDC estimation from 2010-2012, about 52.5 million US adults had some form of arthritis conditions among them persons with age 65 or older reported higher prevalence of arthritis conditions than the other ages due to “wear and tear” on the joints. However, due to lack of proper medication to cure arthritis and higher cost of the medications are hindering the growth of this market over the forecast period.
The global Arthritis Drug market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Arthritis Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Arthritis Drug market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Arthritis Drug in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Arthritis Drug manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
Novartis
Eli Lilly
Celltrion
F. Hoffmann-La Roche
Pfizer
Johnson & Johnson
GSK
...
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
Synthetic DMARDs
Biological DMARDs
NSAIDs
Corticosteroids
Analgesics
Segment by Application
Retail Pharmacies
Hospital Pharmacies
Drug Stores
E-Commerce
Table of Contents
Executive Summary
1 Industry Overview of Arthritis Drug
1.1 Definition of Arthritis Drug
1.2 Arthritis Drug Segment by Type
1.2.1 Global Arthritis Drug Production Growth Rate Comparison by Types (2014-2025)
1.2.2 Synthetic DMARDs
1.2.3 Biological DMARDs
1.2.4 NSAIDs
1.2.5 Corticosteroids
1.2.6 Analgesics
1.3 Arthritis Drug Segment by Applications
1.3.1 Global Arthritis Drug Consumption Comparison by Applications (2014-2025)
1.3.2 Retail Pharmacies
1.3.3 Hospital Pharmacies
1.3.4 Drug Stores
1.3.5 E-Commerce
1.4 Global Arthritis Drug Overall Market
1.4.1 Global Arthritis Drug Revenue (2014-2025)
1.4.2 Global Arthritis Drug Production (2014-2025)
1.4.3 North America Arthritis Drug Status and Prospect (2014-2025)
1.4.4 Europe Arthritis Drug Status and Prospect (2014-2025)
1.4.5 China Arthritis Drug Status and Prospect (2014-2025)
1.4.6 Japan Arthritis Drug Status and Prospect (2014-2025)
1.4.7 Southeast Asia Arthritis Drug Status and Prospect (2014-2025)
1.4.8 India Arthritis Drug Status and Prospect (2014-2025)
2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Arthritis Drug
2.3 Manufacturing Process Analysis of Arthritis Drug
2.4 Industry Chain Structure of Arthritis Drug
3 Development and Manufacturing Plants Analysis of Arthritis Drug
3.1 Capacity and Commercial Production Date
3.2 Global Arthritis Drug Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Arthritis Drug
3.4 Recent Development and Expansion Plans
4 Key Figures of Major Manufacturers
4.1 Arthritis Drug Production and Capacity Analysis
4.2 Arthritis Drug Revenue Analysis
4.3 Arthritis Drug Price Analysis
4.4 Market Concentration Degree
5 Arthritis Drug Regional Market Analysis
5.1 Arthritis Drug Production by Regions
5.1.1 Global Arthritis Drug Production by Regions
5.1.2 Global Arthritis Drug Revenue by Regions
5.2 Arthritis Drug Consumption by Regions
5.3 North America Arthritis Drug Market Analysis
5.3.1 North America Arthritis Drug Production
5.3.2 North America Arthritis Drug Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Arthritis Drug Import and Export
5.4 Europe Arthritis Drug Market Analysis
5.4.1 Europe Arthritis Drug Production
5.4.2 Europe Arthritis Drug Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Arthritis Drug Import and Export
5.5 China Arthritis Drug Market Analysis
5.5.1 China Arthritis Drug Production
5.5.2 China Arthritis Drug Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Arthritis Drug Import and Export
5.6 Japan Arthritis Drug Market Analysis
5.6.1 Japan Arthritis Drug Production
5.6.2 Japan Arthritis Drug Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Arthritis Drug Import and Export
5.7 Southeast Asia Arthritis Drug Market Analysis
5.7.1 Southeast Asia Arthritis Drug Production
5.7.2 Southeast Asia Arthritis Drug Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Arthritis Drug Import and Export
5.8 India Arthritis Drug Market Analysis
5.8.1 India Arthritis Drug Production
5.8.2 India Arthritis Drug Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Arthritis Drug Import and Export
6 Arthritis Drug Segment Market Analysis (by Type)
6.1 Global Arthritis Drug Production by Type
6.2 Global Arthritis Drug Revenue by Type
6.3 Arthritis Drug Price by Type
7 Arthritis Drug Segment Market Analysis (by Application)
7.1 Global Arthritis Drug Consumption by Application
7.2 Global Arthritis Drug Consumption Market Share by Application (2014-2019)
8 Arthritis Drug Major Manufacturers Analysis
8.1 Novartis
8.1.1 Novartis Arthritis Drug Production Sites and Area Served
8.1.2 Novartis Product Introduction, Application and Specification
8.1.3 Novartis Arthritis Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 Eli Lilly
8.2.1 Eli Lilly Arthritis Drug Production Sites and Area Served
8.2.2 Eli Lilly Product Introduction, Application and Specification
8.2.3 Eli Lilly Arthritis Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 Celltrion
8.3.1 Celltrion Arthritis Drug Production Sites and Area Served
8.3.2 Celltrion Product Introduction, Application and Specification
8.3.3 Celltrion Arthritis Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 F. Hoffmann-La Roche
8.4.1 F. Hoffmann-La Roche Arthritis Drug Production Sites and Area Served
8.4.2 F. Hoffmann-La Roche Product Introduction, Application and Specification
8.4.3 F. Hoffmann-La Roche Arthritis Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 Pfizer
8.5.1 Pfizer Arthritis Drug Production Sites and Area Served
8.5.2 Pfizer Product Introduction, Application and Specification
8.5.3 Pfizer Arthritis Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 Johnson & Johnson
8.6.1 Johnson & Johnson Arthritis Drug Production Sites and Area Served
8.6.2 Johnson & Johnson Product Introduction, Application and Specification
8.6.3 Johnson & Johnson Arthritis Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served
8.7 GSK
8.7.1 GSK Arthritis Drug Production Sites and Area Served
8.7.2 GSK Product Introduction, Application and Specification
8.7.3 GSK Arthritis Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.7.4 Main Business and Markets Served
9 Development Trend of Analysis of Arthritis Drug Market
9.1 Global Arthritis Drug Market Trend Analysis
9.1.1 Global Arthritis Drug Market Size (Volume and Value) Forecast 2019-2025
9.2 Arthritis Drug Regional Market Trend
9.2.1 North America Arthritis Drug Forecast 2019-2025
9.2.2 Europe Arthritis Drug Forecast 2019-2025
9.2.3 China Arthritis Drug Forecast 2019-2025
9.2.4 Japan Arthritis Drug Forecast 2019-2025
9.2.5 Southeast Asia Arthritis Drug Forecast 2019-2025
9.2.6 India Arthritis Drug Forecast 2019-2025
9.3 Arthritis Drug Market Trend (Product Type)
9.4 Arthritis Drug Market Trend (Application)
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Arthritis Drug Customers
11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors
12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer
Executive Summary
1 Industry Overview of Arthritis Drug
1.1 Definition of Arthritis Drug
1.2 Arthritis Drug Segment by Type
1.2.1 Global Arthritis Drug Production Growth Rate Comparison by Types (2014-2025)
1.2.2 Synthetic DMARDs
1.2.3 Biological DMARDs
1.2.4 NSAIDs
1.2.5 Corticosteroids
1.2.6 Analgesics
1.3 Arthritis Drug Segment by Applications
1.3.1 Global Arthritis Drug Consumption Comparison by Applications (2014-2025)
1.3.2 Retail Pharmacies
1.3.3 Hospital Pharmacies
1.3.4 Drug Stores
1.3.5 E-Commerce
1.4 Global Arthritis Drug Overall Market
1.4.1 Global Arthritis Drug Revenue (2014-2025)
1.4.2 Global Arthritis Drug Production (2014-2025)
1.4.3 North America Arthritis Drug Status and Prospect (2014-2025)
1.4.4 Europe Arthritis Drug Status and Prospect (2014-2025)
1.4.5 China Arthritis Drug Status and Prospect (2014-2025)
1.4.6 Japan Arthritis Drug Status and Prospect (2014-2025)
1.4.7 Southeast Asia Arthritis Drug Status and Prospect (2014-2025)
1.4.8 India Arthritis Drug Status and Prospect (2014-2025)
2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Arthritis Drug
2.3 Manufacturing Process Analysis of Arthritis Drug
2.4 Industry Chain Structure of Arthritis Drug
3 Development and Manufacturing Plants Analysis of Arthritis Drug
3.1 Capacity and Commercial Production Date
3.2 Global Arthritis Drug Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Arthritis Drug
3.4 Recent Development and Expansion Plans
4 Key Figures of Major Manufacturers
4.1 Arthritis Drug Production and Capacity Analysis
4.2 Arthritis Drug Revenue Analysis
4.3 Arthritis Drug Price Analysis
4.4 Market Concentration Degree
5 Arthritis Drug Regional Market Analysis
5.1 Arthritis Drug Production by Regions
5.1.1 Global Arthritis Drug Production by Regions
5.1.2 Global Arthritis Drug Revenue by Regions
5.2 Arthritis Drug Consumption by Regions
5.3 North America Arthritis Drug Market Analysis
5.3.1 North America Arthritis Drug Production
5.3.2 North America Arthritis Drug Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Arthritis Drug Import and Export
5.4 Europe Arthritis Drug Market Analysis
5.4.1 Europe Arthritis Drug Production
5.4.2 Europe Arthritis Drug Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Arthritis Drug Import and Export
5.5 China Arthritis Drug Market Analysis
5.5.1 China Arthritis Drug Production
5.5.2 China Arthritis Drug Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Arthritis Drug Import and Export
5.6 Japan Arthritis Drug Market Analysis
5.6.1 Japan Arthritis Drug Production
5.6.2 Japan Arthritis Drug Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Arthritis Drug Import and Export
5.7 Southeast Asia Arthritis Drug Market Analysis
5.7.1 Southeast Asia Arthritis Drug Production
5.7.2 Southeast Asia Arthritis Drug Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Arthritis Drug Import and Export
5.8 India Arthritis Drug Market Analysis
5.8.1 India Arthritis Drug Production
5.8.2 India Arthritis Drug Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Arthritis Drug Import and Export
6 Arthritis Drug Segment Market Analysis (by Type)
6.1 Global Arthritis Drug Production by Type
6.2 Global Arthritis Drug Revenue by Type
6.3 Arthritis Drug Price by Type
7 Arthritis Drug Segment Market Analysis (by Application)
7.1 Global Arthritis Drug Consumption by Application
7.2 Global Arthritis Drug Consumption Market Share by Application (2014-2019)
8 Arthritis Drug Major Manufacturers Analysis
8.1 Novartis
8.1.1 Novartis Arthritis Drug Production Sites and Area Served
8.1.2 Novartis Product Introduction, Application and Specification
8.1.3 Novartis Arthritis Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 Eli Lilly
8.2.1 Eli Lilly Arthritis Drug Production Sites and Area Served
8.2.2 Eli Lilly Product Introduction, Application and Specification
8.2.3 Eli Lilly Arthritis Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 Celltrion
8.3.1 Celltrion Arthritis Drug Production Sites and Area Served
8.3.2 Celltrion Product Introduction, Application and Specification
8.3.3 Celltrion Arthritis Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 F. Hoffmann-La Roche
8.4.1 F. Hoffmann-La Roche Arthritis Drug Production Sites and Area Served
8.4.2 F. Hoffmann-La Roche Product Introduction, Application and Specification
8.4.3 F. Hoffmann-La Roche Arthritis Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 Pfizer
8.5.1 Pfizer Arthritis Drug Production Sites and Area Served
8.5.2 Pfizer Product Introduction, Application and Specification
8.5.3 Pfizer Arthritis Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 Johnson & Johnson
8.6.1 Johnson & Johnson Arthritis Drug Production Sites and Area Served
8.6.2 Johnson & Johnson Product Introduction, Application and Specification
8.6.3 Johnson & Johnson Arthritis Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served
8.7 GSK
8.7.1 GSK Arthritis Drug Production Sites and Area Served
8.7.2 GSK Product Introduction, Application and Specification
8.7.3 GSK Arthritis Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.7.4 Main Business and Markets Served
9 Development Trend of Analysis of Arthritis Drug Market
9.1 Global Arthritis Drug Market Trend Analysis
9.1.1 Global Arthritis Drug Market Size (Volume and Value) Forecast 2019-2025
9.2 Arthritis Drug Regional Market Trend
9.2.1 North America Arthritis Drug Forecast 2019-2025
9.2.2 Europe Arthritis Drug Forecast 2019-2025
9.2.3 China Arthritis Drug Forecast 2019-2025
9.2.4 Japan Arthritis Drug Forecast 2019-2025
9.2.5 Southeast Asia Arthritis Drug Forecast 2019-2025
9.2.6 India Arthritis Drug Forecast 2019-2025
9.3 Arthritis Drug Market Trend (Product Type)
9.4 Arthritis Drug Market Trend (Application)
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Arthritis Drug Customers
11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors
12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer
